Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic and epigenetic defects of the RNA modification machinery in cancer
Ines Oršolić, Arnaud Carrier, Manel Esteller
Trends in Genetics (2022) Vol. 39, Iss. 1, pp. 74-88
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17
Charting the epitranscriptomic landscape across RNA biotypes using native RNA nanopore sequencing
Gregor Diensthuber, Eva Maria Novoa
Molecular Cell (2025) Vol. 85, Iss. 2, pp. 276-289
Closed Access | Times Cited: 2
m6A-driven SF3B1 translation control steers splicing to direct genome integrity and leukemogenesis
Maciej Cieśla, Phuong Cao Thi Ngoc, Sowndarya Muthukumar, et al.
Molecular Cell (2023) Vol. 83, Iss. 7, pp. 1165-1179.e11
Open Access | Times Cited: 23
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
RNA editing enzymes: structure, biological functions and applications
Dejiu Zhang, Lei Zhu, Yanyan Gao, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 11
NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m5C methylation
Xuran Zhang, Ke An, Xin Ge, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 10
ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism reprogramming and immune evasion
Qingbo Meng, Yuting Xie, Kang Sun, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Recent advances in the potential role of RNA N4-acetylcytidine in cancer progression
Shujun Zhang, Yafeng Liu, Xiao Ma, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Glucose homeostasis controls N-acetyltransferase 10-mediated ac4C modification of HK2 to drive gastric tumorigenesis
Qiang Wang, Mengmeng Li, Chen Chen, et al.
Theranostics (2025) Vol. 15, Iss. 6, pp. 2428-2450
Open Access | Times Cited: 1
Inflammation in cancer: therapeutic opportunities from new insights
Yifei Xie, Fangfang Liu, Yunfei Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Effects of RNA methylation on Tumor angiogenesis and cancer progression
Mingyu Han, Haifeng Sun, Quanbo Zhou, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 21
The critical roles of m6A RNA methylation in lung cancer: from mechanism to prognosis and therapy
Mei-Ning Diao, Xiao‐Jing Zhang, Yinfeng Zhang
British Journal of Cancer (2023) Vol. 129, Iss. 1, pp. 8-23
Open Access | Times Cited: 18
Dysregulation of Regulatory ncRNAs and Diseases
M. Raafat El-Gewely
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 24-24
Open Access | Times Cited: 18
Revolutionizing in vivo therapy with CRISPR/Cas genome editing: breakthroughs, opportunities and challenges
Arturo Macarrón Palacios, Patrick Korus, Bodo G. C. Wilkens, et al.
Frontiers in Genome Editing (2024) Vol. 6
Open Access | Times Cited: 7
Identification of ALYREF in pan cancer as a novel cancer prognostic biomarker and potential regulatory mechanism in gastric cancer
Yujie Yuan, Yiyang Fan, Wenqing Tang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF)
Xing Ye, Zhouting Tuo, Kai Chen, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 3, pp. 503-515
Open Access | Times Cited: 5
Exploring the role of m7G modification in Cancer: Mechanisms, regulatory proteins, and biomarker potential
Yu Zhang, Weihao Xu, Chuanhui Peng, et al.
Cellular Signalling (2024) Vol. 121, pp. 111288-111288
Closed Access | Times Cited: 5
Relationship between CTF1 gene expression and prognosis and tumor immune microenvironment in glioma
Hong‐Qing Cai, Shen Tian, Ang Liu, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Multifaceted roles of insulin‑like growth factor 2 mRNA binding protein 2 in human cancer (Review)
Jianan Shen, Youxiang Ding
Molecular Medicine Reports (2025) Vol. 31, Iss. 3
Closed Access
The role of lactylation in tumor growth and cancer progression
Khulood Al-Malsi, Sinan Xie, Yunshi Cai, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Therapeutic Potential of FTO Demethylase in Metabolism and Disease Pathways
Chaitanya Sree Somala, S. Sathyapriya, Nagaraj Bharathkumar, et al.
The Protein Journal (2025)
Closed Access
Persistent organic pollutant perfluorooctanoic acid induces alterations in epigenetic modifications of DNA and RNA
Shu-Yi Gu, Tian Feng, Fang-Yin Gang, et al.
Chinese Chemical Letters (2025), pp. 110957-110957
Closed Access
Prognostic analysis and identification of M7G immune-related genes in lung squamous cell carcinoma
Wenhui Li, Nan Wu, Han Jiayi, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top